2) Modulation of the IGF-1 Pathway: Simvastatin promotes apoptosis in colorectal cancer cells by inhibiting IGF-1-induced ERK and Akt expression and further enhancing apoptosis through the downregulation of IGF-1R (Jang et al., 2016). Here, IGF1 is linked to colorectal cancer.